These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Finck BN, Kelly DP. Circulation; 2007 May 15; 115(19):2540-8. PubMed ID: 17502589 [No Abstract] [Full Text] [Related]
3. Metabolic and genetic regulation of cardiac energy substrate preference. Kodde IF, van der Stok J, Smolenski RT, de Jong JW. Comp Biochem Physiol A Mol Integr Physiol; 2007 Jan 15; 146(1):26-39. PubMed ID: 17081788 [Abstract] [Full Text] [Related]
4. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Huss JM, Torra IP, Staels B, Giguère V, Kelly DP. Mol Cell Biol; 2004 Oct 15; 24(20):9079-91. PubMed ID: 15456881 [Abstract] [Full Text] [Related]
5. The PPAR regulatory system in cardiac physiology and disease. Finck BN. Cardiovasc Res; 2007 Jan 15; 73(2):269-77. PubMed ID: 17010956 [Abstract] [Full Text] [Related]
6. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1. Singh KK, Shukla PC, Yanagawa B, Quan A, Lovren F, Pan Y, Wagg CS, Teoh H, Lopaschuk GD, Verma S. J Thorac Cardiovasc Surg; 2013 Sep 15; 146(3):702-9. PubMed ID: 23317938 [Abstract] [Full Text] [Related]
7. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Lehman JJ, Boudina S, Banke NH, Sambandam N, Han X, Young DM, Leone TC, Gross RW, Lewandowski ED, Abel ED, Kelly DP. Am J Physiol Heart Circ Physiol; 2008 Jul 15; 295(1):H185-96. PubMed ID: 18487436 [Abstract] [Full Text] [Related]
8. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction. Faerber G, Barreto-Perreia F, Schoepe M, Gilsbach R, Schrepper A, Schwarzer M, Mohr FW, Hein L, Doenst T. J Thorac Cardiovasc Surg; 2011 Feb 15; 141(2):492-500, 500.e1. PubMed ID: 20447656 [Abstract] [Full Text] [Related]
9. PPAR signaling in the control of cardiac energy metabolism. Barger PM, Kelly DP. Trends Cardiovasc Med; 2000 Aug 15; 10(6):238-45. PubMed ID: 11282301 [Abstract] [Full Text] [Related]
10. Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. Finck BN, Kelly DP. J Mol Cell Cardiol; 2002 Oct 15; 34(10):1249-57. PubMed ID: 12425323 [Abstract] [Full Text] [Related]
11. Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand. Willy PJ, Murray IR, Qian J, Busch BB, Stevens WC, Martin R, Mohan R, Zhou S, Ordentlich P, Wei P, Sapp DW, Horlick RA, Heyman RA, Schulman IG. Proc Natl Acad Sci U S A; 2004 Jun 15; 101(24):8912-7. PubMed ID: 15184675 [Abstract] [Full Text] [Related]
12. Regulation of energy metabolism by long-chain fatty acids. Nakamura MT, Yudell BE, Loor JJ. Prog Lipid Res; 2014 Jan 15; 53():124-44. PubMed ID: 24362249 [Abstract] [Full Text] [Related]
13. Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling. Schilling J, Lai L, Sambandam N, Dey CE, Leone TC, Kelly DP. Circ Heart Fail; 2011 Jul 15; 4(4):474-82. PubMed ID: 21558447 [Abstract] [Full Text] [Related]
14. Methyl donor deficiency induces cardiomyopathy through altered methylation/acetylation of PGC-1α by PRMT1 and SIRT1. Garcia MM, Guéant-Rodriguez RM, Pooya S, Brachet P, Alberto JM, Jeannesson E, Maskali F, Gueguen N, Marie PY, Lacolley P, Herrmann M, Juillière Y, Malthiery Y, Guéant JL. J Pathol; 2011 Nov 15; 225(3):324-35. PubMed ID: 21633959 [Abstract] [Full Text] [Related]
15. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Palomer X, Salvadó L, Barroso E, Vázquez-Carrera M. Int J Cardiol; 2013 Oct 09; 168(4):3160-72. PubMed ID: 23932046 [Abstract] [Full Text] [Related]
16. Diabetic cardiomyopathy. Feuvray D. Arch Mal Coeur Vaiss; 2004 Mar 09; 97(3):261-5. PubMed ID: 15106750 [Abstract] [Full Text] [Related]
17. Peroxisome proliferator-activated receptors and the control of fatty acid oxidation in cardiac hypertrophy. Planavila A, Calvo RR, Vázquez-Carrera M. Mini Rev Med Chem; 2006 Mar 09; 6(3):357-63. PubMed ID: 16515475 [Abstract] [Full Text] [Related]
18. Mitochondrial energy metabolism in heart failure: a question of balance. Huss JM, Kelly DP. J Clin Invest; 2005 Mar 09; 115(3):547-55. PubMed ID: 15765136 [Abstract] [Full Text] [Related]
19. The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. Schreiber SN, Emter R, Hock MB, Knutti D, Cardenas J, Podvinec M, Oakeley EJ, Kralli A. Proc Natl Acad Sci U S A; 2004 Apr 27; 101(17):6472-7. PubMed ID: 15087503 [Abstract] [Full Text] [Related]
20. Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride. Lahey R, Wang X, Carley AN, Lewandowski ED. Circulation; 2014 Nov 11; 130(20):1790-9. PubMed ID: 25266948 [Abstract] [Full Text] [Related] Page: [Next] [New Search]